• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19.

作者信息

Frise Matthew C, Gates Rebecca E V, Curry Nicola S, Danbury Christopher M

机构信息

Royal Berkshire NHS Foundation Trust, Royal Berkshire Hospital, Reading, United Kingdom.

Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom.

出版信息

TH Open. 2020 Dec 15;4(4):e400-e402. doi: 10.1055/s-0040-1721501. eCollection 2020 Oct.

DOI:10.1055/s-0040-1721501
PMID:33336140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7738232/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d4/7738232/7b907fa54b6b/10-1055-s-0040-1721501-i200060-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d4/7738232/7b907fa54b6b/10-1055-s-0040-1721501-i200060-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1d4/7738232/7b907fa54b6b/10-1055-s-0040-1721501-i200060-1.jpg

相似文献

1
Successful Use of Argatroban to Treat a Critically Ill Patient with Coagulopathy and Nephropathy Secondary to COVID-19.成功使用阿加曲班治疗一名继发于新型冠状病毒肺炎的患有凝血病和肾病的重症患者。
TH Open. 2020 Dec 15;4(4):e400-e402. doi: 10.1055/s-0040-1721501. eCollection 2020 Oct.
2
Monitoring of argatroban and lepirudin anticoagulation in critically ill patients by conventional laboratory parameters and rotational thromboelastometry - a prospectively controlled randomized double-blind clinical trial.通过传统实验室参数和旋转血栓弹力图监测危重症患者的阿加曲班和比伐芦定抗凝治疗——一项前瞻性对照随机双盲临床试验
BMC Anesthesiol. 2018 Feb 9;18(1):18. doi: 10.1186/s12871-018-0475-y.
3
Effects of critical illness and organ failure on therapeutic argatroban dosage requirements in patients with suspected or confirmed heparin-induced thrombocytopenia.危重病和器官衰竭对疑似或确诊肝素诱导血小板减少症患者治疗性阿加曲班剂量需求的影响。
Ann Pharmacother. 2009 Jan;43(1):19-27. doi: 10.1345/aph.1L224. Epub 2008 Dec 30.
4
Acute coagulation disorder in a critically ill patient - A case report.一名重症患者的急性凝血障碍——病例报告
J Intensive Care Soc. 2019 Feb;20(1):86-89. doi: 10.1177/1751143718761847. Epub 2018 Mar 5.
5
Argatroban pharmacokinetics and pharmacodynamics in critically ill cardiac surgical patients with suspected heparin-induced thrombocytopenia.阿加曲班在疑似肝素诱导血小板减少症的重症心脏手术患者中的药代动力学和药效学。
Thromb Haemost. 2016 Jun 2;115(6):1081-9. doi: 10.1160/TH15-11-0847. Epub 2016 Jan 21.
6
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.新冠肺炎患者抗凝治疗失败后继发大块肺栓塞采用溶栓及阿加曲班治疗。
Am J Health Syst Pharm. 2020 Nov 16;77(23):1961-1964. doi: 10.1093/ajhp/zxaa287.
7
Prolonged elevation of plasma argatroban in a cardiac transplant patient with a suspected history of heparin-induced thrombocytopenia with thrombosis.心脏移植患者疑似肝素诱导的血小板减少症伴血栓形成，其血浆精氨酸加压素水平持续升高。
Transfusion. 2010 Apr;50(4):801-7. doi: 10.1111/j.1537-2995.2009.02531.x. Epub 2009 Dec 10.
8
Argatroban anticoagulation in critically ill patients.阿加曲班在危重症患者中的抗凝作用。
Ann Pharmacother. 2007 May;41(5):749-54. doi: 10.1345/aph.1H569. Epub 2007 Apr 17.
9
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.危重症患者使用阿加曲班的安全性和经济考量：一项回顾性分析
J Cardiothorac Surg. 2015 Feb 7;10:19. doi: 10.1186/s13019-015-0214-0.
10
A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra) in Critically Ill Patients with Heparin Resistance.一项评估阿加曲班（阿加特拉）对肝素抵抗的危重症患者疗效的前瞻性试点试验。
J Clin Med. 2020 Mar 31;9(4):963. doi: 10.3390/jcm9040963.

引用本文的文献

1
Purinergic signaling: decoding its role in COVID-19 pathogenesis and promising treatment strategies.嘌呤能信号转导：解析其在 COVID-19 发病机制中的作用及有前景的治疗策略。
Inflammopharmacology. 2023 Dec;31(6):3005-3020. doi: 10.1007/s10787-023-01344-4. Epub 2023 Oct 8.

本文引用的文献

1
Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.接受连续性肾脏替代治疗的COVID-19患者的抗凝策略与滤器寿命：单中心经验
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):124-126. doi: 10.2215/CJN.08430520. Epub 2020 Sep 17.
2
Renal replacement therapy in critically ill patients with COVID-19: A retrospective study investigating mortality, renal recovery and filter lifetime.COVID-19 危重症患者的肾脏替代治疗：一项回顾性研究，旨在调查死亡率、肾功能恢复和滤器寿命。
J Crit Care. 2020 Dec;60:103-105. doi: 10.1016/j.jcrc.2020.07.025. Epub 2020 Jul 30.
3
Heparin 2.0: A New Approach to the Infection Crisis.
肝素 2.0：应对感染危机的新方法。
Blood Purif. 2021;50(1):28-34. doi: 10.1159/000508647. Epub 2020 Jul 2.
4
Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19.在重症新型冠状病毒肺炎急性抗凝血酶缺乏患者中使用阿加曲班进行抗凝治疗。
Br J Haematol. 2020 Sep;190(5):e286-e288. doi: 10.1111/bjh.16927. Epub 2020 Jun 30.
5
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.针对 COVID-19 的血栓炎症的药物靶点：综述及对未来研究的启示。
Thromb Haemost. 2020 Jul;120(7):1004-1024. doi: 10.1055/s-0040-1713152. Epub 2020 May 30.
6
Coagulopathy of Coronavirus Disease 2019.新型冠状病毒疾病的凝血功能障碍。
Crit Care Med. 2020 Sep;48(9):1358-1364. doi: 10.1097/CCM.0000000000004458.
7
Heparin resistance in COVID-19 patients in the intensive care unit.COVID-19 患者在重症监护病房中肝素耐药。
J Thromb Thrombolysis. 2020 Aug;50(2):287-291. doi: 10.1007/s11239-020-02145-0.
8
Management of acute kidney injury in patients with COVID-19.COVID-19 患者急性肾损伤的管理。
Lancet Respir Med. 2020 Jul;8(7):738-742. doi: 10.1016/S2213-2600(20)30229-0. Epub 2020 May 14.
9
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
10
Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.病例17 - 2020：一名患有新冠病毒病和急性肾损伤的68岁男性。
N Engl J Med. 2020 May 28;382(22):2147-2156. doi: 10.1056/NEJMcpc2002418. Epub 2020 May 13.